FDG PET shows tumor DNA levels in blood are linked to NSCLC aggressiveness

(Society of Nuclear Medicine and Molecular Imaging) Italian researches have demonstrated a better way of determining the aggressiveness of tumors in patients with advanced non-small cell lung cancer (NSCLC). In a study presented in the featured clinical investigation article of the November issue of The Journal of Nuclear Medicine, they used 18F-fluorodeoxyglucose (FDG) PET/CT imaging to show that the amount of cell-free tumor DNA circulating in the bloodstream correlates with tumor metabolism (linked to cancer aggressiveness), not tumor burden (amount of cancer in the body).
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news